Stilla Technologies

company

About

Stilla Technologies is a Paris-based european biotechnology company.

  • 1 - 10

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
€31M
Industries
Biotechnology,Genetics
Founded date
Jan 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the Naica System.

Taking advantage of cutting-edge microfluidic innovations, Stilla aims to make dPCR a lab commodity to all Life Sciences areas: research, therapeutics, and all the “omics”.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€31M
Stilla Technologies has raised a total of €31M in funding over 2 rounds. Their latest funding was raised on Nov 23, 2021 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 23, 2021 Debt Financing €31M 1 European Investment Bank Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Stilla Technologies is funded by 1 investors. European Investment Bank are the most recent investors.
Investor Name Lead Investor Funding Round
European Investment Bank Yes Debt Financing